GSK’s Use of AI in Vaccine Tech, Drug Discove...

“Not everything is an AI problem,” says IBM Software SVP and Chief Commercial Officer Rob Thomas. In this episode of the Tech Disruptors podcast, Thomas and Bloomberg Intelligence senior technology analyst Anurag Rana discuss IBM’s hybrid cloud and AI strategy, from Red Hat/OpenS ...  Show more

AI demand is scaling and infrastructure complexity is rising. Vultr CEO JJ Kardwell returns to the Bloomberg Intelligence Tech Disruptors podcast with an update on the market’s AI cloud demand. He spoke to BI tech analyst Woo Jin Ho about production AI workloads, GPU utilization ...  Show more

In this DSS Podcast, Anna Anisin welcomes Serg Masís, Climate and Agronomic Data Scientist at Syngenta. Serg, an expert in machine learning interpretability and responsible AI, shares his diverse background and journey into data science. He discusses the challenges of building fa ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ...  Show more

Jimmy Secretan, CTO of JustWin, explores the latest innovations in privacy-preserving neural networks, and explains how JustWin is leveraging AI to help small businesses win government contracts. He also explores the future directions of AI, and the impact of AI on user autonomy ...  Show more